magnifying glass
logo for Barricade Therapeutics

Barricade Therapeutics

Get Full Access

Description

Barricade Therapeutics, Corp. is a privately held biotech company based in Dallas - Fort Worth, TX. Barricade was founded based on discovery and advancement of ... Read More

Headquarters

Headquarters:

1120 South Fwy, Ste 103, Fort Worth, Texas, 76104, United States
Employees

Employees:

<25
Revenue

Revenue:

<$5 Million
SIC Code 28,283
NAICS Code 32541,325
Popular Searches:

Barricade Therapeutics Corp

Barricade Therapeutics , Corp.

Barricade Therapeutics Inc

Barricade Therapeutics

barricadetherapeutics.com

Barricade Therapeutics's Org Chart

Neil Thapar
Neil Thapar

Chief Executive Officer & Scientifi...

PhonePhoneEmailEmail
John Walling
John Walling

Chief Operating Officer

PhonePhoneEmailEmail

PhonePhoneEmailEmail

PhonePhoneEmailEmail

PhonePhoneEmailEmail
Illustration of an envelope

Barricade Therapeutics's Tech Stack

Font Awesome

By

Font Awesome

Office 365

By

Microsoft

Lua

By

PUC-Rio

WordPress.org

By

Automattic

GoDaddy Web Hosting

By

GoDaddy.com

Twitter Cards

By

Twitter
See more technologies

Barricade Therapeutics News & Media

TASIN Selectively Targets Colon Cancer Cells Expressing Truncated APC

HOUSTON--(BUSINESS WIRE)--A study conducted at the Departments of Biochemistry (Jef De Brabander) and Cell Biology (Jerry Shay), University of Texas Southwestern Medical Center, Dallas, TX has demonstrated that TASIN (Truncated APC Selective INhibitor), a recently identified small molecule, selectively kills colorectal cancer cells (CRC) by inducing endoplasmic reticulum (ER) stress which leads to activation of the pro-apoptotic JNK pathway and PARP cleavage. The ER is a central organelle invol

New Preclinical Data for THIO in BRAF-Mutant Mouse Melanoma Models

HOUSTON--(BUSINESS WIRE)--A study conducted at The Wistar Institute in collaboration with The University of Texas Southwestern Medical Center has demonstrated the efficacy of targeting aberrantly active telomerase to treat therapy-resistant melanoma. The research was published in the journal Clinical Cancer Research (http://clincancerres.aacrjournals.org/content/early/2018/03/21/1078-0432.CCR-17-2773). A hallmark of several cancer types, including melanoma, is increased telomerase activation. T
Subscribe to "Barricade Therapeutics" News

Frequently Asked Questions regarding Barricade Therapeutics

Where are Barricade Therapeutics’s headquarters?

Barricade Therapeutics’s headquarters are in 1120 South Fwy, Ste 103, Fort Worth, Texas, 76104, United States

What is Barricade Therapeutics’s official website?

Barricade Therapeutics’s official website is www.barricadetherapeutics.com

What is Barricade Therapeutics’s Revenue?

Barricade Therapeutics’s revenue is <$5 Million

What is Barricade Therapeutics’s SIC code?

Barricade Therapeutics’s SIC: 28,283

What is Barricade Therapeutics’s NAICS code?

Barricade Therapeutics’s NAICS: 32541,325

How many employees are working in Barricade Therapeutics?

Barricade Therapeutics has <25 employees

What is Barricade Therapeutics’s industry?

Barricade Therapeutics is in the industry of: Biotechnology, Pharmaceuticals, Healthcare

What is Barricade Therapeutics's tech stack?

The technologies that are used by Barricade Therapeutics are: Font Awesome, Office 365, Lua, WordPress.org

Who is Barricade Therapeutics's CEO?

Barricade Therapeutics's CEO is Neil Thapar

See more information about Barricade Therapeutics

Browse ZoomInfo’s Directories